Search - tctmd.com

Displaying 221 - 240 of 246

Sort: Relevancy | Date

News Daily News

PROTECT AF: Longer Follow-up Provides Clarity on Watchman vs. Warfarin for A-fib

Caitlin E. Cox

January 30, 2013

News Daily News

PROTECT AF: El Seguimiento a Más Largo Plazo Aclara la Situación del Dispositivo Watchman frente a la Warfarina contra la FA

Caitlin E. Cox

January 30, 2013

News Daily News

Un Dispositivo de Atrapamiento para el Cierre del AAI resulta Seguro y Eficaz en un Pequeño Estudio sobre Fibrilación Auricular

L.A. McKeown

January 16, 2013

News Daily News

Snare Device for LAA Closure Safe, Effective in Small A-fib Study

L.A. McKeown

January 16, 2013

News Conference News TCT 2012

Watchman LAA Effective in Patients Contraindicated for Warfarin

October 26, 2012

News Conference News TCT 2012

Novel Devices Provide Options for LAA Therapy

October 25, 2012

News Industry News

Boston Scientific Demonstrates Ongoing Structural Heart Advances at Transcatheter Cardiovascular Therapeutics 2012 in Miami

October 23, 2012

News Daily News

Un Nuevo Dispositivo Resulta Prometedor para el Cierre Seguro y Eficaz del AAI

Yael L. Maxwell

October 12, 2012

News Daily News

Novel Device Shows Promise for Safe, Effective LAA Closure

Yael L. Maxwell

October 12, 2012

News Daily News

Watchman Device for LAA Closure Provides Net Clinical Benefit vs. Warfarin in A-fib Patients

September 27, 2012

News Daily News

El Dispositivo Watchman para el Cierre del AAI Ofrece Beneficios Clínicos Netos comparado con la Warfarina en Pacientes con FA

September 27, 2012

News Industry News

Boston Scientific WATCHMAN® Left Atrial Appendage Closure Device Receives CE Mark Approval For Expanded Use

August 26, 2012

News Industry News

Boston Scientific Completes Patient Enrollment in PREVAIL Study for First-in-Class WATCHMAN Device

July 02, 2012

News Daily News

Watchman Works Just as Well Without Warfarin-Protected Transition

June 01, 2012

News Daily News

El Watchman Funciona Igual de Bien sin Transición Protegida con Warfarina

June 01, 2012

News Industry News

Study of First-in-Class WATCHMAN® Device Shows 75 Percent Reduction in Stroke Risk in Patients with Atrial Fibrillation Not Eligible for Oral Anticoagulation Therapy

May 11, 2012

News Industry News

Boston Scientific Announces New Clinical Data to be Presented at ACC 2012 on the Market-Leading PROMUS Element™ Stent

March 20, 2012

News Daily News

Lack of Complete Seal with Watchman Device Common, But No Cause for Alarm

Jason Kahn

March 05, 2012

News Daily News

La Falta de Sellado Completo con el Dispositivo Watchman es Común pero No hay Razón para la Alarma

Jason Kahn

March 05, 2012

News Industry News

Boston Scientific's WATCHMAN® Device Implanted in First Patients in Latin America

November 15, 2011

Advertisement

PROTECT AF: Longer Follow-up Provides Clarity on Watchman vs. Warfarin for A-fib

PROTECT AF: El Seguimiento a Más Largo Plazo Aclara la Situación del Dispositivo Watchman frente a la Warfarina contra la FA

Un Dispositivo de Atrapamiento para el Cierre del AAI resulta Seguro y Eficaz en un Pequeño Estudio sobre Fibrilación Auricular

Snare Device for LAA Closure Safe, Effective in Small A-fib Study

Watchman LAA Effective in Patients Contraindicated for Warfarin

Novel Devices Provide Options for LAA Therapy

Boston Scientific Demonstrates Ongoing Structural Heart Advances at Transcatheter Cardiovascular Therapeutics 2012 in Miami

Un Nuevo Dispositivo Resulta Prometedor para el Cierre Seguro y Eficaz del AAI

Novel Device Shows Promise for Safe, Effective LAA Closure

Watchman Device for LAA Closure Provides Net Clinical Benefit vs. Warfarin in A-fib Patients

El Dispositivo Watchman para el Cierre del AAI Ofrece Beneficios Clínicos Netos comparado con la Warfarina en Pacientes con FA

Boston Scientific WATCHMAN® Left Atrial Appendage Closure Device Receives CE Mark Approval For Expanded Use

Boston Scientific Completes Patient Enrollment in PREVAIL Study for First-in-Class WATCHMAN Device

Watchman Works Just as Well Without Warfarin-Protected Transition

El Watchman Funciona Igual de Bien sin Transición Protegida con Warfarina

Study of First-in-Class WATCHMAN® Device Shows 75 Percent Reduction in Stroke Risk in Patients with Atrial Fibrillation Not Eligible for Oral Anticoagulation Therapy

Boston Scientific Announces New Clinical Data to be Presented at ACC 2012 on the Market-Leading PROMUS Element™ Stent

Lack of Complete Seal with Watchman Device Common, But No Cause for Alarm

La Falta de Sellado Completo con el Dispositivo Watchman es Común pero No hay Razón para la Alarma

Boston Scientific's WATCHMAN® Device Implanted in First Patients in Latin America

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content